Arquivamento - Art. 36 §1° da LPI
#11.2
11/24/2020
RPI 2603
Application data
Number
112014023005Type
Filing
Publication
PCT
US2013032551 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 11/24/2020. We update with every new RPI gazette, published weekly.
Applicants
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
US
Inventors
H. L. (pessoa física)
US
J. M. (pessoa física)
US
R. M. (pessoa física)
US
S. T. (pessoa física)
US
S. F. (pessoa física)
US
IPC Classification
Priority claims
US
61/612,290 · 03/17/2012
Abstract
Abstract:FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNEMethods of diagnosing and treating patients afflicted with acne, including diagnosing one as having acne if the individual possesses RT4, RT5, RT7, RT8, RT9, or RT10. Methods for treating acne include administering an effective amount of a drug specifically targeting RT4, RT5, RT7, RT8, RT9, or RT10, such as small molecules, antisense molecules, siRNAs, biologics, antibodies, phages, vaccines, or combination thereof.TRADUÇÃO DO RESUMORESUMODIAGNÓSTICO RÁPIDO E TRATAMENTOS PERSONALIZADOS PARA ACNE Métodos para diagnosticar e tratar pacientes afligidos com acne, incluindo diagnosticar alguém como tendo acne se o indivíduo possuir RT4, RT5, RT7, RT8, RT9 ou RT10. Métodos para tratar acne incluem administrar uma quantidade eficaz de uma droga especificamente dirigida para RT4, RT5, RT7, RT8, RT9 ou RT10, tal como moléculas pequenas, moléculas antissenso, siRNAs, biológicos, anticorpos, fagos, vacinas ou combinação dos mesmos.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
11/24/2020
RPI 2603
#6.21
06/16/2020
RPI 2580
#7.5
05/05/2020
RPI 2574
#7.4
09/17/2019
RPI 2541
#6.6.1
03/27/2018
RPI 2464
#1.3
07/18/2017
RPI 2428
#1.1
10/21/2014
RPI 2285
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.